Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Current Treatment Options in Oncology|February 25, 2022
Allogeneic Chimeric Antigen Receptor Therapy in LymphomaArushi Khurana, Yi LinCancer Journal (Sudbury, Mass.)|June 5, 2020
Role of Microenvironment in Non-Hodgkin Lymphoma: Understanding the Composition and BiologyArushi Khurana, Stephen M AnsellOncotargets and Therapy|July 11, 2019
MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388)Arushi Khurana, Danielle A ShaferJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 12, 2014
Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects!Arushi Khurana, Constantin A DasanuConnecticut Medicine|October 16, 2014
Hepatitis associated aplastic anemia: case report and discussionArushi Khurana, Constantin A DasanuBest Practice & Research. Clinical Haematology|April 1, 2019
Therapy-related myeloid neoplasms in lymphoma survivors: Reducing risksTaha Al-Juhaishi, Arushi Khurana, Danielle ShaferLeukemia & Lymphoma|January 10, 2020
Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphomaArushi Khurana, Philippe Armand, Stephen M AnsellLeukemia & Lymphoma|January 5, 2024
Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trialsSuheil Albert Atallah-Yunes, Arushi Khurana, Matthew MaurerConnecticut Medicine|May 18, 2018
Retroperitoneal, Psoas, and Scrotal Abscesses Due to an Uncommon Organism - Aggregatibacter aphrophilus: Case Report and Review of LiteratureArushi Khurana, N Gurukripa Kowlgi, Edgar R NautBlood Advances|August 14, 2025
Non-DLBCL Monomorphic and Hodgkin Lymphoma PTLD: Clinical Insights and Treatment StrategiesSuheil Albert Atallah-Yunes, Arushi Khurana, Thomas M HabermannPageof 6